Plasma is removed through an IV and centrifuge with the goal of extricating harmful substances such as proteins that cause plaque build-up, autoimmune conditions, arthritis, and even neurodegenerative disorders such as Alzheimers disease
GHK-Cu has increased endothelial proliferation, capillary density, and perfusion in wound and ischemia models, making it of interest in vascular injury and aging studies
Each ingredient plays a complementary role in supporting metabolic health
Food and Drug Administration for any indication
Every dose, schedule, and supply quantity on this page is reported for educational research context and mirrors the published REDEFINE Phase 3 trial protocol
Cyanocobalamin needs to be changed into active forms, while methylcobalamin is ready to use right away